The Department of Hematology & Medical Oncology is comprised of physicians, nurses, researchers, and other healthcare professionals specializing in the diagnosis and treatment of patients with cancers or disorders of the blood, solid organs, or soft tissues.
Cleveland Clinic Hematology and Oncology includes several programs devoted to specific disease or treatments such as chronic leukemia and multiple myeloma, blood and marrow transplantation, and palliative medicine.
Acute Leukemia Program
The Acute Leukemia Program at Cleveland Clinic Taussig Cancer Institute is a worldwide leader in the treatment of acute myeloid and lymphoblastic leukemia. Patients are managed on a dedicated inpatient unit by a multidisciplinary team.
The Acute Leukemia Program features the most innovative treatments including several national studies for which Cleveland Clinic physicians serve as principal investigators. Patients benefit from both the special expertise of the program’s physicians and close collaboration with the Bone Marrow Transplant Program.
Benign Hematology Program
The department offers evaluation, treatment, and consultative services in the field of benign and malignant hematologic disorders. The benign areas include disorders of:
- Red cells, white cells, platelets
- Hemostasis and thrombosis
- Genetic disorders, such as hemoglobinopathies, enzymatic disorders, and the porphyrias
- Diagnostic work up of symptomatic presentations, such as fevers, lymphadenopathy, and complications of solid organ transplantation.
Bone Marrow Failure Program
Dedicated to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS), aplastic anemia, paroxysmal nocturnal hemoglobinuria, and other bone marrow failure conditions, the Bone Marrow Failure program has been recognized as a leader in pioneering diagnostic techniques and therapies by patient groups and national and international treatment and research organizations.
The Bone Marrow Failure program is led by nationally recognized physicians who work closely with specialty nurses and support staff to provide personalized, disease-directed care.
Bone Marrow Transplant Program
Cleveland Clinic’s Blood & Marrow Transplant Program is internationally recognized as a leader in the field. Autologous, allogeneic, non-myeloablative, bone marrow, peripheral stem cell and umbilical cord blood transplants are performed for patients with leukemias, lymphomas, and other hematological malignancies and bone marrow failure states.
As one of the most productive clinical research programs in the world, our physicians have performed over 4,000 bone marrow transplant procedures. Our large referral base and excellent community physician relationships allows for successful continuity of care, making us a leader among bone marrow transplant centers.
Chronic Leukemia Multiple Myeloma Program
The Chronic Leukemia and Multiple Myeloma Program provides patients and physicians access to innovative treatment options, recognized medical expertise, and dedicated support resulting in superior outcomes.
These patients are evaluated and managed by a multidisciplinary team comprised of physicians, nurses and social workers. The program offers patients clinical trials of promising agents and works closely with the lab in developing new, innovative approaches to treatment.
Contact Information for Patient Referrals or Questions:
Debbie Hastings, Department Coordinator
Cancer Answer Line
The better educated the patient and his or her family are about cancer usually results in a better outcome of therapy. A patient who understands the disease will tend to be able to identify problems sooner and is usually able to follow instructions better. The Taussig Cancer Institute provides a Multiple Myeloma Support Group as well as many additional patient support services to assist our patients in his or her time of need.
Cleveland Clinic Chronic Leukemia & Multiple Myeloma Program provides several informational brochures for our patients to review. Please feel free to contact the Cancer Answer Line with any questions or call us locally at 216.445.5008 or toll-free (866.223.8100).
- The International Myeloma Foundation (IMF)
Toll-free (US & Canada): 800.452.CURE (2873)
Phone (Outside US & Canada): 818.487.7455
- The Multiple Myeloma Research Foundation (MMRF)
The treatment of multiple myeloma had not changed the course of the disease significantly until the advent of novel therapies in the last 10 years. Now, many patients can expect long remissions and improved survival as a result of groundbreaking treatment advances. Therefore, we believe that active research and new treatment modalities are necessary to achieve our goals in controlling the disease for longer periods of time in even more patients.
Over the past few years a better understanding of the biology of the disease has resulted in a large flux of new promising agents that are being studied at Cleveland Clinic independently and/or in collaboration with other myeloma institutions in the US, Europe, Australia and Asia. This will allow for better treatments, and will hopefully translate into better quality of life and survival for myeloma patients.
Using a multidisciplinary approach to care with colleagues in the departments of nephrology, radiation oncology, orthopedic surgery and palliative medicine, patients at Cleveland Clinic will receive specialized care in hopes of superior outcomes.
The Cleveland Clinic Chronic Leukemia & Multiple Myeloma Research Program focuses on new drug development, as well as studying the tumor biology to modify its behavior. Over the past few years the research in the biology area has remarkably improved our understanding to develop less toxic and more rational maintenance therapy. Search our database for a listing of clinical trials available at the Taussig Cancer Institute.
Multiple Myeloma Support/Education Group
Cleveland Clinic Chronic Leukemia & Multiple Myeloma Support and Education Group is designed to provide patients and families with a strong support network as well as educate the patient about his or her disease. It is our belief that a better-educated patient will have a greater chance of survival and a better experience during treatment.
The Lymphoma Program is a comprehensive, multidisciplinary effort dedicated to the diagnosis and treatment of Hodgkin and non-Hodgkin lymphoma; education and support of patients and their families; investigation of lymphoma pathobiology; and development of innovative treatments.
We review new patients and pathology specimens at a weekly multidisciplinary clinicopathology conference to ensure accurate diagnosis and determine the best available individualized management. In addition to standard treatments (e.g. chemotherapy, monoclonal antibodies, radioimmunoconjugates and hematopoietic stem cell transplantation), we also have available many novel agents such as monoclonal antibodies, vaccines, and targeted therapies.
The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center is a nationally recognized leader in the diagnosis and treatment of primary and metastatic spine, nerve, and brain tumors, and their effects on the nervous system. Annually, the Burkhardt Brain Tumor Center physicians record approximately 8,000 patient visits and perform more than 900 surgeries.
Cleveland Clinic's Comprehensive Breast Cancer Program is unique in its multidisciplinary approach to breast cancer treatment, prevention and detection. Here, you will find a full array of services, from initial screening and diagnosis to innovative breast cancer treatment and supportive counseling.
Our multidisciplinary approach to colon cancer care unites specialists from across Cleveland Clinic, including surgeons, gastroenterologists, radiologists, anesthesiologists, psychologists and oncologists.
Cleveland Clinic's team of colorectal specialists provides patients with personalized treatment plans and some of the best long-term outcomes in the world.
Gynecologic Oncology Program
Gynecologic cancers affect a woman's reproductive organs, including cervix, uterus, ovaries, fallopian tubes, vagina and vulva. The American Cancer Society estimates each year, approximately 98,000 women are diagnosed with a cancer of the reproductive organ.
Head and Neck Program
Our doctors specialize in head and neck cancer, laryngology & tracheal reconstruction, nasal & sinus disorders, otology, vestibular & balance disorders and voice box cancer.
In addition to providing general adult and pediatric otolaryngology services, the Head & Neck Institute provides several highly specialized tertiary care services through its various sections.
Cleveland Clinic lung cancer specialists are nationally recognized for diagnosing and treating lung and chest cancer through our Chest Cancer Center and Lung Nodule Clinic. Our team provides the newest medical and surgical treatment options available for lung cancer today with survival rates of patients consistently 5 to 20 percent higher than the national average.
Patients with a complex, life-threatening illness often have unrelieved cancer symptoms and significant physical difficulties sometime during their illness. Specially trained staff in the Harry R. Horvitz Center for Palliative Medicine at Cleveland Clinic Taussig Cancer Institute coordinate the complex medical care for patients as they face the physical and psychological challenges associated with their illness and the pain related to cancer symptoms.
Prostate cancer remains the second leading cause of cancer death in men, yet it is highly curable if discovered while still confined to the prostate gland. Each year, Cleveland Clinic physicians provide prostate cancer treatment for more than 1,000 men.
Renal Cell Program
Kidney cancer, also known as renal cancer, or renal cell carcinoma, is a condition that occurs when cells in the kidney grow uncontrollably, creating a tumorous mass.
Cleveland Clinic is know around the world for its advances in the treatment of kidney disease, including cancer. In the past, the typical kidney cancer treatment was the removal of the entire kidney, called total nephrectomy. Cleveland Clinic urologists have the world's largest experience in partial nephrectomy, removing only the cancerous part of the kidney. This kidney-sparing surgery, which is just as effective but keeps kidney tissue that may be required later in life, requires surgical expertise in both kidney reconstruction and vascular surgery techniques.
Taussig Oncology Program for Seniors (TOPS)
If you are 75 or older and have been diagnosed with cancer, you may benefit from a specialized assessment at Taussig Cancer Institute's Geriatric Oncology Clinic. The assessment is designed to identify and manage problems related to a cancer diagnosis and treatment that may otherwise get overlooked. The assessment's goal is to improve your quality of life, offer reassurance to you and your family, and empower you to make informed health care decisions.